{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:11:44Z","timestamp":1788880304974,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03482-8","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:44:41Z","timestamp":1788878681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["pH-Responsive Chitosan-Coated Spanlastic Nanovesicles for Enhanced Lung-Targeted Delivery of Brilliant Blue G in Acute Lung Injury"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-3847","authenticated-orcid":false,"given":"Elsayed A.","family":"Elmorsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-0480","authenticated-orcid":false,"given":"Ahmed Y.","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-7851","authenticated-orcid":false,"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-6867","authenticated-orcid":false,"given":"Abdulaziz A.","family":"Alsalloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-213X","authenticated-orcid":false,"given":"Mostafa M.","family":"Khodeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3465-4470","authenticated-orcid":false,"given":"Rabab S.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-0262","authenticated-orcid":false,"given":"Mohamed A. M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-0566","authenticated-orcid":false,"given":"Hamad","family":"Alsaykhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-1321","authenticated-orcid":false,"given":"Mohammed","family":"Alorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-7836","authenticated-orcid":false,"given":"Anis Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9145-7150","authenticated-orcid":false,"given":"Mohamed R.","family":"Abdel-Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-7162","authenticated-orcid":false,"given":"Manal M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-0687","authenticated-orcid":false,"given":"Hagir H. T.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-2640","authenticated-orcid":false,"given":"Syed Suhail","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8587-5598","authenticated-orcid":false,"given":"Abdelrahman","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4875-0705","authenticated-orcid":false,"given":"Maha M.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3482_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12931-025-03137-5","volume":"26","author":"K Zhou","year":"2025","unstructured":"Zhou K, Qin Q, Lu J. Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives. Respir Res. 2025;26:54.","journal-title":"Respir Res"},{"issue":"6","key":"3482_CR2","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1177\/08971900221108713","volume":"36","author":"MB Chudow","year":"2023","unstructured":"Chudow MB, Condeni MS, Dhar S, Heavner MS, Nei AM, Bissell BD. Current practice review in the management of acute respiratory distress syndrome. J Pharm Pract. 2023;36(6):1454\u201371.","journal-title":"J Pharm Pract"},{"key":"3482_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","volume":"81","author":"MR Carmo","year":"2014","unstructured":"Carmo MR, Menezes APF, Nunes ACL, Pli\u00e1ssova A, Rolo AP, Palmeira CM, et al. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology. 2014;81:142\u201352.","journal-title":"Neuropharmacology"},{"key":"3482_CR4","doi-asserted-by":"publisher","first-page":"112723","DOI":"10.1016\/j.biopha.2022.112723","volume":"148","author":"MH Zohny","year":"2022","unstructured":"Zohny MH, Cavalu S, Youssef ME, Kaddah MM, Mourad AA, Gaafar AGA, et al. Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-\u03baB and NLRP3 crosstalk: a novel approach for filling an unmet medical need. Biomed Pharmacother. 2022;148:112723, 112723.","journal-title":"Biomed Pharmacother"},{"key":"3482_CR5","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.12659\/MSM.915865","volume":"25","author":"X Zhou","year":"2019","unstructured":"Zhou X, Yang Y, Wu L, Wang Y, Du C, Li C, et al. Brilliant blue G inhibits inflammasome activation and reduces disruption of blood\u2013spinal cord barrier induced by spinal cord injury in rats. Medical science monitor: international medical journal of experimental and clinical research. 2019;25:6359.","journal-title":"Medical science monitor: international medical journal of experimental and clinical research"},{"key":"3482_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01861-2","volume":"21","author":"JMS Pereira","year":"2020","unstructured":"Pereira JMS, Barreira AL, Gomes CR, Ornellas FM, Ornellas DS, Miranda LC, et al. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats. BMC Nephrol. 2020;21:1\u201311.","journal-title":"BMC Nephrol"},{"key":"3482_CR7","doi-asserted-by":"publisher","first-page":"119123","DOI":"10.1016\/j.lfs.2021.119123","volume":"270","author":"S Saber","year":"2021","unstructured":"Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats. Life Sci. 2021;270:119123, 119123.","journal-title":"Life Sci"},{"issue":"3","key":"3482_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/molecules25030745","volume":"25","author":"BG de la Torre","year":"2019","unstructured":"de la Torre BG, Albericio F. The pharmaceutical industry in 2019. An analysis of FDA drug approvals from the perspective of molecules. Molecules. 2019;25(3):745.","journal-title":"Molecules"},{"issue":"1\u20133","key":"3482_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molstruc.2010.01.015","volume":"968","author":"Y-S Li","year":"2010","unstructured":"Li Y-S, Ge Y-S, Zhang Y, Zhang A-Q, Sun S-F, Jiang F-L, et al. Interaction of coomassie brilliant blue G250 with human serum albumin: probing of the binding mechanism and binding site by spectroscopic and molecular modeling methods. J Mol Struct. 2010;968(1\u20133):24\u201331.","journal-title":"J Mol Struct"},{"issue":"7","key":"3482_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041229","volume":"7","author":"DE Kimbler","year":"2012","unstructured":"Kimbler DE, Shields J, Yanasak N, Vender JR, Dhandapani KM. Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS ONE. 2012;7(7):e41229.","journal-title":"PLoS ONE"},{"issue":"6","key":"3482_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/1567205013666160208142456","volume":"13","author":"A Irwin","year":"2016","unstructured":"Irwin A, Erisir A, Kwon I. Oral triphenylmethane food dye analog, brilliant blue G, prevents neuronal loss in APPSwDI\/NOS2-\/-mouse model. Curr Alzheimer Res. 2016;13(6):663\u201377.","journal-title":"Curr Alzheimer Res"},{"key":"3482_CR12","doi-asserted-by":"crossref","unstructured":"Vukovac EL, Lozo M, Mise K, Gudelj I, Puljiz \u017d, Jurcev-Savicevic A, et al. Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study. Med Sci Monit. 2014;20:255.","DOI":"10.12659\/MSM.889800"},{"issue":"23","key":"3482_CR13","doi-asserted-by":"publisher","first-page":"19338","DOI":"10.18632\/oncotarget.4907","volume":"6","author":"L Li","year":"2015","unstructured":"Li L, Chow VT, Tan NS. Targeting vascular leakage in lung inflammation. Oncotarget. 2015;6(23):19338.","journal-title":"Oncotarget"},{"key":"3482_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","volume":"413","author":"S Kakkar","year":"2011","unstructured":"Kakkar S, Kaur IP. Spanlastics\u2014a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413:202\u201310.","journal-title":"Int J Pharm"},{"key":"3482_CR15","doi-asserted-by":"crossref","unstructured":"Saini H, Rapolu Y, Razdan K, Nirmala, Sinha VR. Spanlastics: a novel elastic drug delivery system with potential applications via multifarious routes of administration. Journal of Drug Targeting. 2023;31(10):999\u20131012.","DOI":"10.1080\/1061186X.2023.2274805"},{"issue":"28","key":"3482_CR16","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.2174\/0113816128313398240613063019","volume":"30","author":"L Kumar","year":"2024","unstructured":"Kumar L, Rana R, Kukreti G, Aggarwal V, Chaurasia H, Sharma P, et al. Overview of Spanlastics: A Groundbreaking Elastic Medication Delivery Device with Versatile Prospects for Administration via Various Routes. Curr Pharm Des. 2024;30(28):2206\u201321.","journal-title":"Curr Pharm Des"},{"key":"3482_CR17","doi-asserted-by":"crossref","unstructured":"Kira AY, Abdelhamid AM, Nasr M. Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification. Journal of Drug Delivery Science and Technology. 2024:105644.","DOI":"10.1016\/j.jddst.2024.105644"},{"issue":"9","key":"3482_CR18","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1021\/acs.molpharmaceut.3c00542","volume":"20","author":"M Nasr","year":"2023","unstructured":"Nasr M, Kira AY, Saber S, Essa EA, El-Gizawy SA. Lactosylated chitosan nanoparticles potentiate the anticancer effects of telmisartan in vitro and in a N-Nitrosodiethylamine-induced mice model of hepatocellular carcinoma. Mol Pharm. 2023;20(9):4758\u201369.","journal-title":"Mol Pharm"},{"issue":"3","key":"3482_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","volume":"81","author":"A Bernkop-Schn\u00fcrch","year":"2012","unstructured":"Bernkop-Schn\u00fcrch A, D\u00fcnnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3482_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/polym10030267","volume":"10","author":"M Ways","year":"2018","unstructured":"Ways M, Lau WM, Khutoryanskiy VV. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers (Basel). 2018;10(3):267.","journal-title":"Polymers (Basel)"},{"key":"3482_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113000","volume":"141","author":"AY Kira","year":"2024","unstructured":"Kira AY, Elmorsy EA, Hamad RS, Abdel-Reheim MA, Elhemely MA, Khalaf NEA, et al. Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NF\u03baB\/NLRP3\/IL-1\u03b2 signaling in rats: Unraveling new roles beyond calcium channel blocking. Int Immunopharmacol. 2024;141:113000.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"3482_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1586\/ers.10.71","volume":"4","author":"H Chen","year":"2010","unstructured":"Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010;4(6):773\u201383. https:\/\/doi.org\/10.1586\/ers.10.71.","journal-title":"Expert Rev Respir Med"},{"key":"3482_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101732","volume":"58","author":"SA El-Gizawy","year":"2020","unstructured":"El-Gizawy SA, Nouh A, Saber S, Kira AY. Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats. Journal of Drug Delivery Science and Technology. 2020;58:101732.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"8","key":"3482_CR24","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","volume":"110","author":"HM Eid","year":"2021","unstructured":"Eid HM, Naguib IA, Alsantali RI, Alsalahat I, Hegazy AM. Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin. J Pharm Sci. 2021;110(8):3027\u201336.","journal-title":"J Pharm Sci"},{"key":"3482_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2023.100332","volume":"6","author":"G Nerli","year":"2023","unstructured":"Nerli G, Robla S, Bartalesi M, Luceri C, D\u2019Ambrosio M, Csaba N, et al. Chitosan coated niosomes for nose-to-brain delivery of clonazepam: formulation, stability and permeability studies. Carbohydrate Polymer Technologies and Applications. 2023;6:100332.","journal-title":"Carbohydrate Polymer Technologies and Applications"},{"issue":"9","key":"3482_CR26","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/microorganisms11092247","volume":"11","author":"SZ Alshawwa","year":"2023","unstructured":"Alshawwa SZ, El-Masry TA, Nasr M, Kira AY, Alotaibi HF, Sallam A-S, et al. Celecoxib-loaded cubosomal nanoparticles as a therapeutic approach for Staphylococcus aureus in vivo infection. Microorganisms. 2023;11(9):2247.","journal-title":"Microorganisms"},{"issue":"6","key":"3482_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1208\/s12249-023-02605-9","volume":"24","author":"M Nasr","year":"2023","unstructured":"Nasr M, Kira AY, Saber S, Essa EA, El-Gizawy SA. Telmisartan-loaded lactosylated chitosan nanoparticles as a liver specific delivery system: synthesis, optimization and targeting efficiency. AAPS PharmSciTech. 2023;24(6):144.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"3482_CR28","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3892\/mmr.2019.10561","volume":"20","author":"M Ju","year":"2019","unstructured":"Ju M, He H, Chen S, Liu Y, Liu Y, Pan S, et al. Ulinastatin ameliorates LPS\u2011induced pulmonary inflammation and injury by blocking the MAPK\/NF\u2011\u03baB signaling pathways in rats. Mol Med Rep. 2019;20(4):3347\u201354. https:\/\/doi.org\/10.3892\/mmr.2019.10561.","journal-title":"Mol Med Rep"},{"key":"3482_CR29","doi-asserted-by":"publisher","unstructured":"Ehrentraut H, Weisheit CK, Frede S, Hilbert T. Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation. J Vis Exp. 2019;(149). https:\/\/doi.org\/10.3791\/59999.","DOI":"10.3791\/59999"},{"issue":"Suppl 1","key":"3482_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40635-020-00350-y","volume":"8","author":"L Chimenti","year":"2020","unstructured":"Chimenti L, Morales-Quinteros L, Puig F, Camprubi-Rimblas M, Guillamat-Prats R, G\u00f3mez MN, et al. Comparison of direct and indirect models of early induced acute lung injury. Intensive Care Med Exp. 2020;8:62. https:\/\/doi.org\/10.1186\/s40635-020-00350-y.","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"3482_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12951-021-00803-w","volume":"19","author":"L Wang","year":"2021","unstructured":"Wang L, Rao Y, Liu X, Sun L, Gong J, Zhang H, et al. Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung. J Nanobiotechnology. 2021;19(1):56, 56. https:\/\/doi.org\/10.1186\/s12951-021-00803-w.","journal-title":"J Nanobiotechnology"},{"issue":"37","key":"3482_CR32","doi-asserted-by":"publisher","first-page":"24218","DOI":"10.1021\/acsomega.1c03816","volume":"6","author":"M Barani","year":"2021","unstructured":"Barani M, Sargazi S, Hajinezhad MR, Rahdar A, Sabir F, Pardakhty A, et al. Preparation of pH-responsive vesicular deferasirox: Evidence from in silico, in vitro, and in vivo evaluations. ACS Omega. 2021;6(37):24218\u201332.","journal-title":"ACS Omega"},{"issue":"1","key":"3482_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/nanofab-2020-0100","volume":"6","author":"S Sargazi","year":"2021","unstructured":"Sargazi S, Hosseinikhah SM, Zargari F, Chauhana NPS, Hassanisaadi M, Amani S. pH-responsive cisplatin-loaded niosomes: Synthesis, characterization, cytotoxicity study and interaction analyses by simulation methodology. Nanofabrication. 2021;6(1):1\u201315.","journal-title":"Nanofabrication"},{"key":"3482_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijpharm.2014.06.041","volume":"472","author":"AM Al-Mahallawi","year":"2014","unstructured":"Al-Mahallawi AM, Khowessah OM, Shoukri RA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm. 2014;472:304\u201314.","journal-title":"Int J Pharm"},{"issue":"3","key":"3482_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/ph15030348","volume":"15","author":"RM Zaki","year":"2022","unstructured":"Zaki RM, Alfadhel MM, Alshahrani SM, Alsaqr A, Al-Kharashi LA, Anwer MK. Formulation of chitosan-coated brigatinib nanospanlastics: optimization, characterization, stability assessment and in-vitro cytotoxicity activity against H-1975 cell lines. Pharmaceuticals. 2022;15(3):348.","journal-title":"Pharmaceuticals"},{"issue":"12","key":"3482_CR36","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/pharmaceutics14122627","volume":"14","author":"WS Alharbi","year":"2022","unstructured":"Alharbi WS, Hareeri RH, Bazuhair M, Alfaleh MA, Alhakamy NA, Fahmy UA, et al. Spanlastics as a potential platform for enhancing the brain delivery of flibanserin: In vitro response-surface optimization and in vivo pharmacokinetics assessment. Pharmaceutics. 2022;14(12):2627.","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"3482_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0927-7765(03)00080-8","volume":"30","author":"A Manosroi","year":"2003","unstructured":"Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf, B. 2003;30(1\u20132):129\u201338.","journal-title":"Colloids Surf, B"},{"issue":"5","key":"3482_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/pharmaceutics14051024","volume":"14","author":"SM Badr-Eldin","year":"2022","unstructured":"Badr-Eldin SM, Aldawsari HM, Alhakamy NA, Fahmy UA, Ahmed OA, Neamatallah T, et al. Merging experimental design and nanotechnology for the development of optimized simvastatin spanlastics: a promising combined strategy for augmenting the suppression of various human cancer cells. Pharmaceutics. 2022;14(5):1024.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3482_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/0122117385348551241028102256","volume":"13","author":"HK Alkufi","year":"2025","unstructured":"Alkufi HK, Kassab HJ. Soluplus-stabilized nimodipine-entrapped spanlastic formulations prepared with edge activator (Tween20): Comparative physicochemical evaluation. Pharmaceutical Nanotechnology. 2025;13(3):551\u201363.","journal-title":"Pharmaceutical Nanotechnology"},{"key":"3482_CR40","volume":"8","author":"M Said","year":"2024","unstructured":"Said M, Ali KM, Alfadhel MM, Afzal O, Aldosari BN, Alsunbul M, et al. Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; Preparation, I-optimal optimization, and In-vivo evaluation. International Journal of Pharmaceutics: X. 2024;8:100293.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"3482_CR41","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S319348","author":"MA Abdelbari","year":"2021","unstructured":"Abdelbari MA, El-Mancy SS, Elshafeey AH, Abdelbary AA. Implementing spanlastics for improving the ocular delivery of clotrimazole: in vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. Int J Nanomedicine. 2021. https:\/\/doi.org\/10.2147\/IJN.S319348.","journal-title":"Int J Nanomedicine"},{"key":"3482_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2021.127246","volume":"627","author":"S Rathod","year":"2021","unstructured":"Rathod S, Arya S, Shukla R, Ray D, Aswal VK, Bahadur P, et al. Investigations on the role of edge activator upon structural transitions in Span vesicles. Colloids Surf, A. 2021;627:127246.","journal-title":"Colloids Surf, A"},{"issue":"1","key":"3482_CR43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10717544.2021.1886377","volume":"28","author":"M Elhabak","year":"2021","unstructured":"Elhabak M, Ibrahim S, Abouelatta SM. Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin. Drug Delivery. 2021;28(1):445\u201353.","journal-title":"Drug Delivery"},{"key":"3482_CR44","doi-asserted-by":"publisher","first-page":"1546010","DOI":"10.3389\/fphar.2025.1546010","volume":"16","author":"EA Elmorsy","year":"2025","unstructured":"Elmorsy EA, Saber S, Al-Majdoub ZM, Hamad RS, Abdel-Reheim MA, Ramadan A, et al. Innovative pH-responsive alginate-coated rosuvastatin-loaded chitosan nanoparticles: a targeted approach to inhibiting HMGB1-activated RAGE\/TLR4-NF\u03baB signaling in colonic inflammation in rats. Front Pharmacol. 2025;16:1546010.","journal-title":"Front Pharmacol"},{"issue":"12","key":"3482_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/pharmaceutics16121574","volume":"16","author":"A Abu Koush","year":"2024","unstructured":"Abu Koush A, Popa EG, Pricop DA, Nita L, Foia C-I, Pauna A-M, et al. Enhanced stability and in vitro biocompatibility of chitosan-coated lipid vesicles for indomethacin delivery. Pharmaceutics. 2024;16(12):1574, 1574.","journal-title":"Pharmaceutics"},{"key":"3482_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106127","volume":"100","author":"M Nasr","year":"2024","unstructured":"Nasr M, Kira AY, Saber S. Localized delivery of roxadustat via cubosomes-based thermosensitive in-situ hydrogel enhances diabetic wound healing by stabilizing HIF-1\u03b1 in rats. Journal of Drug Delivery Science and Technology. 2024;100:106127.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3482_CR47","doi-asserted-by":"publisher","first-page":"1377980","DOI":"10.3389\/fphar.2024.1377980","volume":"15","author":"EA Elmorsy","year":"2024","unstructured":"Elmorsy EA, Saber S, Kira AY, Alghasham A, Abdel-Hamed MR, Amer MM, et al. Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles. Front Pharmacol. 2024;15:1377980, 1377980.","journal-title":"Front Pharmacol"},{"key":"3482_CR48","doi-asserted-by":"crossref","unstructured":"Hua S. Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. International journal of nanomedicine. 2014:735\u201344.","DOI":"10.2147\/IJN.S55805"},{"key":"3482_CR49","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S261932","author":"M Yaghoobian","year":"2020","unstructured":"Yaghoobian M, Haeri A, Bolourchian N, Shahhosseni S, Dadashzadeh S. The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S261932.","journal-title":"Int J Nanomedicine"},{"key":"3482_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106439","volume":"103","author":"S Saber","year":"2025","unstructured":"Saber S, Nasr M, Yahya G, Elagamy HI, Zaid MHA, Sharaf H, et al. Silk fibroin\/gelatin electrospun nanofibrous dressing loaded with roxadustat accelerates wound healing in diabetic rats via HIF-1\u03b1 stabilization. Journal of Drug Delivery Science and Technology. 2025;103:106439.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3482_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106088","volume":"100","author":"NW Mohamed","year":"2024","unstructured":"Mohamed NW, Sabry SA, Mahdy MA, Faisal MM. Tailoring of spanlastics for promoting transdermal delivery of irbesartan: In vitro characterization, ex vivo permeation and in vivo assessment. Journal of Drug Delivery Science and Technology. 2024;100:106088.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1","key":"3482_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/10717544.2017.1410262","volume":"25","author":"AM Fahmy","year":"2018","unstructured":"Fahmy AM, El-Setouhy DA, Ibrahim AB, Habib BA, Tayel SA, Bayoumi NA. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Delivery. 2018;25(1):12\u201322.","journal-title":"Drug Delivery"},{"key":"3482_CR53","doi-asserted-by":"publisher","first-page":"138233","DOI":"10.1016\/j.ijbiomac.2024.138233","volume":"284","author":"Z Fang","year":"2025","unstructured":"Fang Z, Wang L, Zhang X, Pei X, Zhou L, Nie T, et al. Muco-adhesive chitosan-coated polyphenol nanoparticle for treatment of infectious acute pneumonia through sustained pulmonary delivery of polymyxin B. Int J Biol Macromol. 2025;284:138233, 138233.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"3482_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/0113894501301747240417103321","volume":"25","author":"W Alwahsh","year":"2024","unstructured":"Alwahsh W, Sahudin S, Alkhatib H, Bostanudin MF, Alwahsh M. Chitosan-based nanocarriers for pulmonary and intranasal drug delivery systems: a comprehensive overview of their applications. Curr Drug Targets. 2024;25(7):492\u2013511.","journal-title":"Curr Drug Targets"},{"key":"3482_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","volume":"351","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. J Control Release. 2022;351:923\u201340.","journal-title":"J Control Release"},{"key":"3482_CR56","doi-asserted-by":"crossref","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. International journal of nanomedicine. 2012:5577\u201391.","DOI":"10.2147\/IJN.S36111"},{"issue":"23","key":"3482_CR57","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1016\/S0142-9612(03)00331-4","volume":"24","author":"B Heurtault","year":"2003","unstructured":"Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P. Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003;24(23):4283\u2013300.","journal-title":"Biomaterials"},{"issue":"4","key":"3482_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1208\/s12249-022-02217-9","volume":"23","author":"MD Ansari","year":"2022","unstructured":"Ansari MD, Saifi Z, Pandit J, Khan I, Solanki P, Sultana Y, et al. Spanlastics a novel nanovesicular carrier: Its potential application and emerging trends in therapeutic delivery. AAPS PharmSciTech. 2022;23(4):112.","journal-title":"AAPS PharmSciTech"},{"key":"3482_CR59","doi-asserted-by":"crossref","unstructured":"Laffleur F. Mucoadhesive chitosan in drug delivery. In: Chitosan for Biomaterials V: Insight into Pharmaceutical Uses. Springer; 2024. p. 143\u201360.","DOI":"10.1007\/12_2024_180"},{"key":"3482_CR60","doi-asserted-by":"publisher","unstructured":"Abdelhady R, Saber S, Ahmed Abdel-Reheim M, Mohammad S. Alamri M, Alfaifi J, I. E. Adam M, et al. Unveiling the therapeutic potential of exogenous \u03b2-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis. Frontiers in pharmacology. 2023;Volume 14 - 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1239025.","DOI":"10.3389\/fphar.2023.1239025"},{"key":"3482_CR61","doi-asserted-by":"publisher","first-page":"112723","DOI":"10.1016\/j.biopha.2022.112723","volume":"148","author":"MH Zohny","year":"2022","unstructured":"Zohny MH, Cavalu S, Youssef ME, Kaddah MMY, Mourad AAE, Gaafar AGA, et al. Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-\u03baB and NLRP3 crosstalk: a novel approach for filling an unmet medical need. Biomed Pharmacother. 2022;148:112723, 112723. https:\/\/doi.org\/10.1016\/j.biopha.2022.112723.","journal-title":"Biomed Pharmacother"},{"key":"3482_CR62","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.12659\/msm.915865","volume":"25","author":"X Zhou","year":"2019","unstructured":"Zhou X, Yang Y, Wu L, Wang Y, Du C, Li C, et al. Brilliant Blue G inhibits inflammasome activation and reduces disruption of blood-spinal cord barrier induced by spinal cord injury in rats. Med Sci Monit. 2019;25:6359\u201366. https:\/\/doi.org\/10.12659\/msm.915865.","journal-title":"Med Sci Monit"},{"key":"3482_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119123","volume":"270","author":"S Saber","year":"2021","unstructured":"Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats. Life Sci. 2021;270:119123. https:\/\/doi.org\/10.1016\/j.lfs.2021.119123.","journal-title":"Life Sci"},{"key":"3482_CR64","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00167f","author":"DD Singh","year":"2025","unstructured":"Singh DD. NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives. RSC Med Chem. 2025. https:\/\/doi.org\/10.1039\/d5md00167f.","journal-title":"RSC Med Chem"},{"key":"3482_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175963","author":"C Panicucci","year":"2020","unstructured":"Panicucci C, Raffaghello L, Bruzzone S, Baratto S, Principi E, Minetti C, et al. eATP\/P2X7R axis: an orchestrated pathway triggering inflammasome activation in muscle diseases. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21175963.","journal-title":"Int J Mol Sci"},{"key":"3482_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cellimm.2018.12.001","volume":"336","author":"NJ Geraghty","year":"2019","unstructured":"Geraghty NJ, Watson D, Sluyter R. Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease. Cell Immunol. 2019;336:12\u20139. https:\/\/doi.org\/10.1016\/j.cellimm.2018.12.001.","journal-title":"Cell Immunol"},{"issue":"5","key":"3482_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061405","volume":"8","author":"R Bhargava","year":"2013","unstructured":"Bhargava R, Janssen W, Altmann C, Andr\u00e9s-Hernando A, Okamura K, Vandivier RW, et al. Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS One. 2013;8(5):e61405. https:\/\/doi.org\/10.1371\/journal.pone.0061405.","journal-title":"PLoS One"},{"issue":"1","key":"3482_CR68","doi-asserted-by":"publisher","first-page":"L105","DOI":"10.1152\/ajplung.00470.2006","volume":"293","author":"AK Sharma","year":"2007","unstructured":"Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2007;293(1):L105\u201313. https:\/\/doi.org\/10.1152\/ajplung.00470.2006.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"3482_CR69","doi-asserted-by":"publisher","first-page":"9269154","DOI":"10.1155\/2018\/9269154","volume":"2018","author":"Z Cao","year":"2018","unstructured":"Cao Z, Liu J-L, Wu S, Wang Q. Mechanism of MCP-1 in acute lung injury and advanced therapy by drug-loaded dextrin nanoparticle. Int J Polym Sci. 2018;2018(1):9269154, 9269154. https:\/\/doi.org\/10.1155\/2018\/9269154.","journal-title":"Int J Polym Sci"},{"key":"3482_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174940","volume":"924","author":"R Ren","year":"2022","unstructured":"Ren R, Xu Z, Wang X, Jiang W, Yu P. Verdiperstat attenuates acute lung injury by modulating MPO\/\u03bc-calpain\/\u03b2-catenin signaling. Eur J Pharmacol. 2022;924:174940. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174940.","journal-title":"Eur J Pharmacol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03482-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:44:44Z","timestamp":1788878684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03482-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":70,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3482"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03482-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"268"}}